Review International journal of molecular sciences · 2026 Amyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review. Kurdi MA, Alotaibi H, Alkhuraymi AT, et al. Akkermansia muciniphila PubMed ↗
Review Frontiers in immunology · 2026 Targeting gut-brain-immune axis in amyotrophic lateral sclerosis. Mudda NS, Zhang L, Sampelli P Akkermansia muciniphila PubMed ↗
Systematic review Molecular neurobiology · 2025 Microbiota Dysbiosis in Amyotrophic Lateral Sclerosis: A Systematic Review of Human Studies. Gautam P, Vishwakarma RK, Nath M, et al. Escherichia coli PubMed ↗
Cell reports · 2026 C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen. McCourt B, Lemr K, Chakrabarti S, et al. Parabacteroides merdae PubMed ↗
Gut microbes · 2024 Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice. Zhang Y, Xia Y, Sun J Bacteroides fragilis PubMed ↗
Gut microbes · 2024 Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Yan J, Chen H, Zhang Y, et al. Bacteroides stercorisBacteroides uniformisFaecalibacterium prausnitziiPhocaeicola vulgatus PubMed ↗
Animal study PLoS biology · 2026 A gut-activated NHR-86-CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis. Sang Y, Ren J, Aballay A Enterococcus faecium PubMed ↗
Observational Amyotrophic lateral sclerosis & frontotemporal degeneration · 2020 The human gut microbiota in people with amyotrophic lateral sclerosis. Nicholson K, Bjornevik K, Abu-Ali G, et al. Agathobacter rectalisRoseburia intestinalis PubMed ↗
Review Gut microbes · 2020 Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gotkine M, Kviatcovsky D, Elinav E Akkermansia muciniphila PubMed ↗
Randomized trial Journal of clinical gastroenterology · 2018 Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies. Mazzini L, Mogna L, De Marchi F, et al. Escherichia coliLigilactobacillus salivarius PubMed ↗
Nature · 2019 Potential roles of gut microbiome and metabolites in modulating ALS in mice. Blacher E, Bashiardes S, Shapiro H, et al. [Ruminococcus] torquesAkkermansia muciniphilaParabacteroides distasonis PubMed ↗